LIMK1 and central nervous system cancer: Inhibit the viability and proliferation of glioma cells by arresting the cell cycle at the G1/S phase, and disrupt the structure of the cytoskeleton and affect F-actin depolymerization via the p-LIMK/cofilin pathway